Woburn, Massachusetts Clinical Trials

A listing of Woburn, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 80 clinical trials
Featured trial
test12 (test12)

test12

Online studies
  • 0 views
  • 22 May, 2025
  • Online study
Featured trial
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine  

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

acute treatment
lasmiditan
migraine
ly573144
migraine in children
MedVadis Research Corp
 (7.9 away)
  • 0 views
  • 19 Feb, 2024
  • +164 other locations
Featured trial
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

A Phase I study to evaluate the safety of a novel, orally available, selective, and potent small molecule inhibitor of the histone lysine methyl transferase MMSET (also known as NSD2/WHSC1) to prevent the dimethylation of H3K36 in adult patients with relapsed or refractory multiple myeloma (RRMM).

Massachusetts General Hospital
 (9.4 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +17 other locations
Featured trial
A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma  

This research is being done to determine if the combination of the Dendritic Cell (DC)/ Multiple Myeloma (MM) fusion vaccine with elranatamab is safe and effective in treating Relapsed or Refractory Multiple Myeloma (MM).The names of the study drugs and vaccine involved in this study are:DC/MM fusion vaccine (a personalized …

Beth Israel Deaconess Medical Center
 (9.8 away)
  • 0 views
  • 27 Mar, 2026
  • +1 other locations
Featured trial
Elranatamab in R/R Multiple Myeloma

This research is being done to see if the study drug, elranatamab, reduces the risk of disease progression (worsening disease) after idecabtagene vicleucel in relapsed refractory multiple myeloma.

Massachusetts General Hospital
 (9.4 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +2 other locations
Featured trial
TriPRIL CAR T Cells in Multiple Myeloma

This research study involves the study of TriPRIL CAR T Cells for treating people with relapsed or refractory multiple myeloma and to understand the side effects when treated with TriPRIL CAR T Cells.This research study involves the study drugs:.TriPRIL CAR T CellsFludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part …

Massachusetts General Hospital Cancer Center
 (9.4 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • 1 location
Cookie Testing  

Cookie Testing

Online studies
Site
(online study)
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
RJ_StudyVirtualF  

Acne

Online studies
Site1_RJ_StudyVirtual1N
(online study)
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
T2

we

Online studies
8260013
(online study) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707)  

Primary Objectives:Evaluate the safety and tolerability of THOR-707 as a single agent and as a combination therapy (identify Dose Limiting Toxcitiy (DLTs) in Cohorts A, B, C, D, and G, and adverse events (AEs)/serious adverse event (SAE) profile in Cohorts A, B, C, D, E, F, and G)Define the Maximium …

Formal Site
(online study)
  • 0 views
  • 04 Apr, 2025
  • 1 location
  • Online study